Burning Rock Biotech (BNR) Net Income (2019 - 2025)

Burning Rock Biotech's Net Income history runs 7 years deep, the most recent figure standing at -$1.9 million for Q4 2025.

• In Q4 2025, Net Income rose 79.87% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at -$7.3 million (up 84.26% YoY), while the FY2025 annual figure was -$7.8 million, up 83.57% from the prior year.
• Net Income was -$1.9 million for Q4 2025 at Burning Rock Biotech, up from -$2.3 million in the prior quarter.
• In the past five years, Net Income ranged from a high of -$1.3 million in Q2 2025 to a low of -$41.2 million in Q1 2022.
• Historically, Net Income has averaged -$20.7 million across 5 years, with a median of -$23.2 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Net Income slumped 247.3% in 2021, then surged 91.43% in 2025.
• A 5-year view of Net Income shows it stood at -$39.8 million in 2021, then grew by 22.56% to -$30.8 million in 2022, then grew by 26.79% to -$22.5 million in 2023, then jumped by 57.06% to -$9.7 million in 2024, then soared by 79.87% to -$1.9 million in 2025.
• The last three Net Income figures came in at -$1.9 million (Q4 2025), -$2.3 million (Q3 2025), and -$1.3 million (Q2 2025), per Business Quant data.